References
Arunlakshana O, Schild HO. Some quantitative uses of drug antagonism. British Journal of Pharmacology 14: 48–58, 1959
De Crée J, Leempoels J, Geukens H, De Cock W, Verhaegen H. The antihypertensive effect of ketanserin (R 41 468) a novel 5-HT blocking agent, in patients with essential hypertension. Clinical Science 61: 473s–476s, 1981
Fozard JR. Mechanism of the hypotensive effect of ketanserin. Journal of Cardiovascular Pharmacology 4: 829–838, 1982
Vanhoutte PM. Serotonin and the cardiovascular system, Raven Press, New York, 1985
Van Nueten JM, Janssen PAJ, Van Beek J, Xhonneux R, Verbeuren TJ, et al. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT serotonergic receptors. Journal of Pharmacology and Experimental Therapeutics 218: 217–230, 1981
Waud DR, Parker RB. Pharmacological estimation of drug-receptor dissociation constants. Statistical evaluation II. Competitive antagonists. Journal of Pharmacology and Experimental Therapeutics 177: 13–24, 1971
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Salvati, P., Vaghi, F., Colombo, M. et al. A New Selective Antagonist of Vascular Serotonin Receptors Lowers Blood Pressure in Spontaneously Hypertensive Rats. Drugs 36 (Suppl 1), 105–109 (1988). https://doi.org/10.2165/00003495-198800361-00019
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800361-00019